Apimeds Pharmaceuticals US APUS
NYSE APUS
$4.41 +0.02 (+0.34%)
At close: Aug 20, 2026 · 10:51 AM UTC

Apimeds Pharmaceuticals US (APUS) EPS (Diluted) (2024 - 2025)

Apimeds Pharmaceuticals US (APUS) EPS (Diluted) (2024 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Haleon 43.65 Bn 42.68 Bn - -
2 Teva Pharmaceutical Industries 43.09 Bn 39.44 Bn 2.15 Bn -0.49
3 Zoetis 31.54 Bn 29.86 Bn 1.05 Bn 2.07
4 Takeda Pharmaceutical 28.61 Bn 22.81 Bn 5.10 Bn 0.45
5 United Therapeutics 22.11 Bn 19.45 Bn 683.80 Mn 7.27
6 Viatris 18.77 Bn 17.88 Bn 1.46 Bn -0.10
7 Neurocrine Biosciences 15.62 Bn 15.23 Bn 935.80 Mn 1.39
8 Elanco Animal Health 12.07 Bn 11.54 Bn 798.00 Mn 0.11
9 Dr Reddys Laboratories 10.09 Bn 9.93 Bn - -
10 Apimeds Pharmaceuticals US 7.52 Mn 7.52 Mn - -5.53

Historic Data

Download Data
DateValue
Dec 31, 2025 -6.69
Sep 30, 2025 -1.43
Jun 30, 2025 -2.58
Mar 31, 2025 -0.51
Dec 31, 2024 -0.49
Sep 30, 2024 -0.42
Jun 30, 2024 -0.57
Mar 31, 2024 -0.38